πŸ‡ΊπŸ‡Έ FDA
Patent

US 10858347

Multicyclic compounds and uses thereof

granted A61PA61P35/00

Quick answer

US patent 10858347 (Multicyclic compounds and uses thereof) held by Karyopharm Therapeutics Inc. expires Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Karyopharm Therapeutics Inc.
Grant date
Tue Dec 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 03 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61P, A61P35/00